Study in Elderly Patients With Early Breast Cancer (ICE)

NCT00196859 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Ibandronate, Capecitabine
DRUG: Ibandronate

Sponsor

GBG Forschungs GmbH

Collaborators

[object Object]
[object Object]